RecruitingNot ApplicableNCT07086638

ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer

ROS-Scavenging Nanozyme Combined With Near-Infrared Thermotherapy for the Amelioration of Grade III Radiation Dermatitis in Patients With Head and Neck Cancer


Sponsor

West China Hospital

Enrollment

5 participants

Start Date

Jul 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Severe radiation dermatitis remains a challenging complication in head and neck cancer with limited treatment options; this study aims to evaluate a novel Prussian blue-based nanozyme combined with near-infrared thermotherapy to promote effective healing of Grade III lesions.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new topical treatment that combines a special antioxidant nanoparticle (ROS-scavenging nanozyme) with heat therapy to prevent and treat radiation dermatitis — the painful skin burns that commonly develop during radiation therapy in head and neck cancer patients. **You may be eligible if...** - You have been diagnosed with a head and neck cancer (non-metastatic, confirmed by pathology) - You are scheduled to receive high-dose radiotherapy, either as your primary treatment or after surgery **You may NOT be eligible if...** - Your overall health status is poor (ECOG performance status above 2) - You already have a skin rash, open wound, or ulceration in the treatment area - You are allergic to trolamine or Prussian blue (components of the treatment) - You have inflammatory or connective tissue skin conditions - You have previously received radiation to the head and neck area Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPhoto-responsive nanozyme

The nanozyme scavenges ROS at the site of dermatitis and simultaneously responds to NIR light to generate mild heat, thereby promoting the healing of radiation-induced skin injury.


Locations(1)

Sichuan University West China Hospital

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07086638


Related Trials